Cyberonics (CYBX) Jumps on Lazard Upgrade

Shares of Cyberonics (Nasdaq: CYBX) are surging today on the back of an upgrade over at Lazard Capital Markets. Cyberonics most recently traded at $16.43, up $2.06, or 14% from yesterday's close.

Lazard raised its investment rating on Cyberonics from Hold to Buy.

Cyberonics, Inc., a neuromodulation company, engages in the design, development, manufacture, and marketing of implantable medical devices that provide vagus nerve stimulation (VNS) therapy for the treatment of epilepsy and treatment-resistant depression.

You May Also Be Interested In

• Wells Fargo Upgrades Portland General Electric Company (POR) to Overweight
• JPMorgan Upgrades TIC Solutions (TIC) to Neutral
• Citi upgrades O-I Glass to Buy with $9 price target, opens 90-Day upside catalyst watch